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PAIN RELIEF, FUNCTIONAL RECOVERY AND ASSOCIATED MEDICAL
TREATMENTS REDUCTION IN LARGE-SCALE POPULATION WITH
OSTEOARTHRITIS RECEIVING INJECTIONS OF VISCOSUPPLEMENT
INCORPORATING HIGH CONCENTRATION OF SORBITOL
F. Radenne. Aptissen SA, Meyrin, Switzerland
Purpose: Synolis V-A is a visco-antalgic composed of highly con-
centrated non-crosslinked hyaluronic acid (2%) from biofermentation
origin combined with a high concentration of Sorbitol (4%). Sorbitol is
an endogenous molecule which functions as an oxygen free radical
(OFR) scavenger. We hypothesize that anti-oxidant effect of sorbitol
may play an active role in rapid and strong pain reduction in patients
with osteoarthritis, and therefore inﬂuence function recovery and
medication intake reduction.
Methods: 1147 patients with a majority suffering from knee Osteo-
arthritis (92.9%), were enrolled in a Non-Interventional Study con-
ducted in 398 centres in Germany. Studied population had an average
age of 63.3 years, including 499 males and 614 females, and was dis-
tributed into the following grades according to Kellgren–Lawrence
scale: Grade I – 6.7%, Grade II – 31.4%, Grade III – 48.0% and Grade IV –
13.9%. Patients were assessed for pain level and functional impairment
using 5 points Likert scale (scoring from 0 ¼ None to 4 ¼ Very Severe).
Patients received between 1 and 3 intraarticular (IA) injections of 2 ml
of Synolis V-A. Selected primary criteria were variations of pain and
function impairment scores, between baseline and following the time
points: week1, week 12 and week 24. Selected secondary criterion was
the evaluation of concomitant medical treatments (topical, NSAID,
corticosteroids and analgesics) prior to treatment initiation and at
week 24.
Results: Selected Histological Measures from Best Subset Regression
Modeling: Average pain level (pooled data) scored at 2.61 (n ¼ 1125) at
baseline, 1.68 (n¼ 832) at week 1, 1.14 (n¼ 1085) at week 12 and 1.07 (n
¼ 1030) at week 24. Average functional impairment level (pooled data)
scored at 1.99 (n ¼ 1103) at baseline, 1.47 (n ¼ 819) at week 1, 1.07 (n ¼
1074) at week 12 and 1.02 (n ¼ 1031) at week 24. Patients with no
reported medical treatment increased by 120%, from 354 patients
before treatment initiation to 780 at week 24. Average daily medication
per patient decreased by 72% from 1.30 before treatment initiation to
0.37 at week 24. Out of 1147 patients only 24 adverse events (AEs) were
reported for 22 patients (1.9%), the most common Adverse Event being
“Injection site joint pain”.
Conclusions: This study suggests that a strong pain relief occurs
immediately after the ﬁrst injection of Synolis V-A, with a relief that
ampliﬁes until week 24.Functional improvement had been observed to
follow a similar trend than pain relief. With a baseline score slightly
lower, the amplitude of the observed improvement was also slightly
inferior to that of pain relief. Never-the-less, both average scores ended
up around 1 (Mild) at week 24. The trend similarities between pain
relief and functional improvement suggest a direct link between both
factors; link that can be explained by the impact of pain on loss of
function. Not surprisingly, pain reduction and function recovery were
associated with an important drop in medication intake.
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THE RELATIONSHIP BETWEEN MENTAL HEALTH AND FOOT PAIN
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Purpose: Although mental health is related to the persistence of
musculoskeletal pain, our understanding of the association between
mental health and foot pain is limited. Subsequently, we conducted
a three year longitudinal study to examine in a community based
population.
Methods: Eighty-three community dwelling participants (mean body
mass index 35.3 kg/m2  9.0) who had foot pain at study inception in
2008, and for whom measures of mental health (Mental Component
Summary of the Short Form-36) were available, were invited to take
part in this follow-up study in 2011. Change in foot painwas determined
by the difference between the Manchester Foot Pain and Disability
Index score at baseline and follow up; therefore, a decrease in the score
indicates improved foot pain and an increase indicates deterioration infoot pain. Linear regression was used to determine the factors affecting
change in foot pain.
Results: Of the 62 respondents (75% response rate, 49 females and 13
males), there were 27 (44%) whose foot pain deteriorated. A higher
Mental Component Summary score of the Short Form-36 at baselinewas
associatedwith a slower progression of foot pain (beta coefﬁcient0.29,
95% conﬁdence interval 0.42 to 0.01); adjusted for age, sex, body
mass index and physical health.
Conclusion: Mental health is associated with changes in foot pain.
Clinicians dealing with this population should consider the contribution
of mental health in their management and treatment of foot pain.
Pain: Clinical
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CROSS-SECTIONAL AND LONGITUDINAL ASSOCIATIONS BETWEEN
KNEE JOINT EFFUSION AND KNEE PAIN IN OLDER ADULTS
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Purpose: Knee pain is one of the most prominent symptoms of osteo-
arthritis (OA). Joint synovial effusion could contribute to pain, but the
relationship between effusion and knee pain remains controversial.
Effects of joint effusions at different knee compartments on knee pain
are unclear. Aim of this study was to determine the cross-sectional and
longitudinal associations between knee joint effusions at different
compartments and knee pain in older adults.
Methods: Population-based cohort study of older adults randomly
selected from local community (N¼ 976,mean age 62.3 years, range from
50 to 80; 50.1% females). Knee joint effusions were measured at baseline
using T2weightedmagnetic resonance imaging (MRI) at 4 compartments
(suprapatellar pouch, central portion, posterior femoral recess, and sub-
popliteal recess). Other structural changes including cartilage defects,
bone marrow lesions and meniscal lesions were assessed by MRI. OARSI
atlaswasused to assess kneeosteophytes, joint spacenarrowing (JSN) and
radiographic OA. Knee pain was assessed by self-administered Western
Ontario and McMasters osteoarthritis index (WOMAC) questionnaire at
baseline and 2.6 years later. The 5WOMAC pain subscales were clinically
constructed into weight-bearing pain (including painwhenwalking on a
ﬂat surface, going up/down stairs, and when standing) and non-weight-
bearing pain (including pain at nightwhile in bed andwhen sitting/lying).
Univariable andmultivariable logistic regression analysis and generalized
linear models with Poisson regression analysis were used to estimate
prevalence ratios (PR) or relative risks (RR) for the association between
knee effusion (0–3) and baseline or increases in knee pain.
Results: Prevalence of knee joint effusion (2) was 42.9% at supra-
patellar pouch, 48.8% at central portion, 10.3% at posterior femoral
recess and 14.4% at subpopliteal recess. Cross-sectionally, knee effusion
at suprapatellar pouch was signiﬁcantly associated with total (PR: 1.26,
95% CI 1.08–1.48) and non-weight bearing knee pain (PR: 1.24, 95% CI
1.06–1.46), but not with weight-bearing pain, after adjustment for age,
gender, BMI, rheumatoid arthritis, radiographic OA and other knee
structures. Joint effusions at other compartments were not signiﬁcantly
associated with knee pain.
Longitudinally, effusion at suprapatellar pouch was associated with
increases in total (RR: 1.20, 95% CI 1.00–1.44), non-weight-bearing (RR:
1.38, 95% CI 1.09–1.75) and weight-bearing knee pain (RR: 1.26, 95% CI
1.04–1.53) after adjustment for above covariates. Effusions at posterior
femoral recess and central portion were associated with increases in
non-weight-bearing knee pain (RR: 1.55, 95% CI 1.25–1.91 and RR: 1.29,
95% CI 1.01–1.65; respectively) but not with weight-bearing knee pain.
Effusion at subpopliteal recess was signiﬁcantly associated with an
increase in total knee pain (RR: 1.16, 95% CI 1.01–1.32) after adjustment
for age, sex and BMI, but became non-signiﬁcant after further adjust-
ment for radiographic OA and other knee structures.
Conclusions: Knee joint effusions may have compartment-speciﬁc
contributions to knee pain in older adults. While suprapatellar pouch
effusion is associated with both non-weight-bearing and weight-bear-
ing knee pain, posterior femoral recess and central portion effusions are
only associated with non-weight-bearing knee pain.
